T-Cell Immunity

T-cell immunity is the cellular arm of the adaptive immune response, in which T lymphocytes recognize antigen presented on MHC molecules and either help other immune cells or directly kill infected cells. In vaccinology it underpins protection against pathogens that antibodies alone cannot control and shapes the help that drives durable antibody and memory responses.

Definition

T-cell immunity is the component of adaptive immunity mediated by T lymphocytes that recognize peptide antigens presented by major histocompatibility complex molecules, comprising CD4+ helper cells that orchestrate the response and CD8+ cytotoxic cells that eliminate infected cells.

Scope

The topic covers CD4+ helper and CD8+ cytotoxic T cells, how they are activated and differentiate, the concept of T-cell quality (polyfunctionality) in protection, and why T-cell responses matter for vaccines against intracellular and chronic pathogens. It is a mechanistic and conceptual reference, not guidance on measuring T-cell responses in individual patients.

Core questions

• How are CD4+ and CD8+ T cells activated and differentiated after vaccination?
• What features of a T-cell response (magnitude, quality, phenotype) relate to protection?
• For which vaccines and pathogens is cellular immunity decisive rather than antibody alone?

Key concepts

• CD4+ helper T cells
• CD8+ cytotoxic T cells
• MHC-restricted antigen presentation
• T-cell polyfunctionality (quality)
• Th1 / Th2 / Tfh differentiation
• Cell-mediated protection against intracellular pathogens

Mechanisms

Antigen-presenting cells display pathogen-derived peptides on MHC class II to CD4+ T cells and class I to CD8+ T cells; with appropriate costimulation and cytokine signals, naive T cells proliferate and differentiate into effector subsets. CD4+ cells polarize into helper lineages (including follicular helper cells that drive antibody affinity maturation), while CD8+ cells become cytotoxic lymphocytes that kill infected cells. Seder and colleagues emphasized that the quality of the T-cell response — particularly polyfunctional cells producing multiple cytokines — can matter as much as its magnitude for protection, and Farber and colleagues described how human memory T cells are generated and distributed across tissue compartments.

Clinical relevance

T-cell immunity explains why protection against some pathogens, especially intracellular and chronic infections, depends on cellular rather than humoral readouts, and why some vaccine evaluations include T-cell assays. This entry describes the cellular response at the level of mechanism and evidence; it is not a basis for ordering or interpreting immune-cell testing in individual care.

Epidemiology

For pathogens such as Mycobacterium tuberculosis and several viral infections, cellular immunity is central to control, and vaccine development for these targets evaluates T-cell responses alongside or instead of antibody. Plotkin's framework notes that for a subset of vaccines a cellular correlate, rather than an antibody titre, best reflects protection.

History

The distinction between humoral and cell-mediated immunity emerged in the mid-twentieth century, and the recognition of MHC restriction in the 1970s established how T cells see antigen. Later work on helper-cell subsets, cytotoxic effector function, and the polyfunctional quality of T-cell responses connected cellular immunology to rational vaccine design.

Debates

Should vaccine evaluation rely on T-cell magnitude or quality?

Total numbers of antigen-specific T cells do not always predict protection; the quality of the response, including polyfunctionality and tissue localization, may be more informative, complicating the choice of a cellular correlate of protection.

Key figures

• Robert Seder
• Mario Roederer
• Donna Farber

Seminal works

• seder-2008
• farber-2014

Frequently asked questions

How does T-cell immunity differ from antibody immunity?

Antibody (humoral) immunity is mediated by soluble antibodies that act on pathogens and toxins outside cells, whereas T-cell immunity is cell-mediated: CD8+ T cells kill infected cells and CD4+ T cells coordinate the broader response. The two arms are complementary, and many vaccines engage both.

Why do some vaccines target T-cell responses?

For pathogens that live inside cells or cause chronic infection, antibodies may be insufficient, so protection relies on T cells that recognize and eliminate infected cells. Vaccines against such targets are designed and evaluated with cellular immunity in mind.